Published in Purinergic Signal on December 19, 2006
Microglial activation in stroke: therapeutic targets. Neurotherapeutics (2010) 1.84
Traumatic brain injury, neuroinflammation, and post-traumatic headaches. Headache (2013) 1.19
P2 receptors for extracellular nucleotides in the central nervous system: role of P2X7 and P2Y₂ receptor interactions in neuroinflammation. Mol Neurobiol (2012) 0.94
The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice. Int J Neuropsychopharmacol (2012) 0.93
Norepinephrine modulates the motility of resting and activated microglia via different adrenergic receptors. J Biol Chem (2013) 0.92
Hypoxia/reoxygenation impairs memory formation via adenosine-dependent activation of caspase 1. J Neurosci (2012) 0.91
Mechanisms and potential therapeutic applications of microglial activation after brain injury. CNS Neurosci Ther (2014) 0.89
Neuroprotective roles of the P2Y(2) receptor. Purinergic Signal (2012) 0.84
Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death. Purinergic Signal (2012) 0.83
Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease. Mol Neurodegener (2011) 0.82
Neuronal and glial purinergic receptors functions in neuron development and brain disease. Front Cell Neurosci (2013) 0.80
Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes. Front Mol Neurosci (2016) 0.80
Microglia P2Y₆ receptors mediate nitric oxide release and astrocyte apoptosis. J Neuroinflammation (2014) 0.78
P2X receptors in neuroglia. Wiley Interdiscip Rev Membr Transp Signal (2012) 0.77
P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential. CNS Neurol Disord Drug Targets (2012) 0.77
Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy? Clin Ophthalmol (2009) 0.75
Emerging role of extracellular nucleotides and adenosine in multiple sclerosis. Purinergic Signal (2011) 0.75
Purinergic receptors as potential therapeutic targets in Alzheimer's disease. Neuropharmacology (2015) 0.75
The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science (1996) 7.10
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature (2003) 6.04
Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol (2000) 4.06
Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem (2002) 3.99
Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood (2001) 3.84
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain (2005) 3.37
ATP released from astrocytes mediates glial calcium waves. J Neurosci (1999) 2.92
Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol (1997) 2.81
P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med (2004) 2.78
Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem (2001) 2.63
Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J Neurosci (2001) 2.54
Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J Exp Med (1997) 2.52
Storage and release of ATP from astrocytes in culture. J Biol Chem (2002) 2.50
Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J Neurosci (2004) 2.09
ATP released from astrocytes during swelling activates chloride channels. J Neurophysiol (2003) 2.05
Autocrine signaling through ATP release represents a novel mechanism for cell volume regulation. Proc Natl Acad Sci U S A (1996) 2.04
Tissue distribution of the P2X7 receptor. Neuropharmacology (1997) 1.90
ATP released via gap junction hemichannels from the pigment epithelium regulates neural retinal progenitor proliferation. Neuron (2005) 1.87
P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J Biol Chem (2003) 1.87
Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem Int (2001) 1.86
Cell damage excites nociceptors through release of cytosolic ATP. Pain (2002) 1.82
A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J Neurosci (2004) 1.66
Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J Neurochem (2000) 1.63
Kinetics and mechanism of ATP-dependent IL-1 beta release from microglial cells. J Immunol (2000) 1.61
Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J Immunol (1996) 1.60
ATP release through connexin hemichannels in corneal endothelial cells. Invest Ophthalmol Vis Sci (2005) 1.60
P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett (1999) 1.54
ATP-mediated cytotoxicity in microglial cells. Neuropharmacology (1997) 1.48
Extracellular ATP activates transcription factor NF-kappaB through the P2Z purinoreceptor by selectively targeting NF-kappaB p65. J Cell Biol (1997) 1.48
Connexins: functions without junctions. Curr Opin Cell Biol (2004) 1.47
Microglial activation by purines and pyrimidines. Glia (2002) 1.45
Extracellular ATP in T-lymphocyte activation: possible role in effector functions. Proc Natl Acad Sci U S A (1990) 1.45
ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-gamma. J Immunol (2001) 1.36
Regulation of ion channels by ABC transporters that secrete ATP. Science (1995) 1.31
Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells. Br J Pharmacol (1997) 1.30
Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain. Eur J Neurosci (2000) 1.29
Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitro. Eur J Neurosci (2003) 1.28
Adenosine transporters. Gen Pharmacol (1996) 1.26
Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci (2005) 1.25
P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc Natl Acad Sci U S A (2004) 1.25
Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia. Brain Res Brain Res Rev (2005) 1.24
ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors. Neurochem Int (1998) 1.24
Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J Neurochem (1987) 1.22
P2X7 receptor expression after ischemia in the cerebral cortex of rats. J Neuropathol Exp Neurol (2004) 1.21
Cannabinoid receptors in microglia of the central nervous system: immune functional relevance. J Leukoc Biol (2005) 1.21
Stimulation-dependent release of adenosine triphosphate from hippocampal slices. Brain Res (1989) 1.20
Mechanisms underlying extracellular ATP-evoked interleukin-6 release in mouse microglial cell line, MG-5. J Neurochem (2001) 1.19
Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J Neurochem (1996) 1.17
P2X7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells. J Biol Chem (1999) 1.14
ABC transporter-facilitated ATP conductive transport. Am J Physiol (1999) 1.14
ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels. J Neurosci (2002) 1.11
Production of adenosine from extracellular ATP at the striatal cholinergic synapse. J Neurochem (1993) 1.10
Nucleoside transporters of mammalian cells. Pharm Biotechnol (1999) 1.09
Glial cells express multiple ATP binding cassette proteins which are involved in ATP release. Neuroreport (2002) 1.09
Spinal cord injury induces early and persistent lesional P2X4 receptor expression. J Neuroimmunol (2005) 1.04
ATP- and adenosine-mediated signaling in the central nervous system: chronic pain and microglia: involvement of the ATP receptor P2X4. J Pharmacol Sci (2004) 1.03
P2X7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells. J Neurochem (2003) 1.02
Evidence for functional adenosine A3 receptors in microglia cells. J Neurochem (2003) 1.01
Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J Neurochem (1996) 1.00
Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism. Mol Cell Neurosci (2002) 1.00
Expression of P2X receptors on rat microglial cells during early development. Glia (2005) 0.99
Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions. J Neurochem (1993) 0.99
P2 Purinoceptor expression and functional changes of hypoxia-activated cultured rat retinal microglia. Neurosci Lett (2000) 0.98
Involvement of P2 purinoceptors and the nitric oxide pathway in [3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices. Brain Res (1999) 0.97
Two different ionotropic receptors are activated by ATP in rat microglia. J Physiol (1999) 0.97
Extracellular ATP activates a cation conductance and a K+ conductance in cultured microglial cells from mouse brain. J Neurosci (1993) 0.95
P2X7 receptor modulation of beta-amyloid- and LPS-induced cytokine secretion from human macrophages and microglia. J Neuroimmunol (2004) 0.95
Widespread expression of ecto-apyrase (CD39) in the central nervous system. Brain Res (1998) 0.95
Characterization and possible function of adenosine 5'-triphosphate receptors in activated rat microglia. Br J Pharmacol (1994) 0.94
Characterization and transduction mechanisms of purinoceptors in activated rat microglia. Br J Pharmacol (1994) 0.94
Endogenous hemichannels play a role in the release of ATP from Xenopus oocytes. J Cell Physiol (2006) 0.92
Potent effect of interleukin-1 beta to evoke ATP and adenosine release from rat hippocampal slices. J Neuroimmunol (2004) 0.92
The P2Z/P2X7 receptor of microglial cells: a novel immunomodulatory receptor. Prog Brain Res (1999) 0.92
Differential activation of subtype purinergic receptors modulates Ca(2+) mobilization and COX-2 in human microglia. Glia (2003) 0.92
ATP-induced membrane currents in ameboid microglia acutely isolated from mouse brain slices. Neuroscience (1996) 0.91
ATP stimulation of Ca2+ -dependent plasminogen release from cultured microglia. Br J Pharmacol (1998) 0.90
ATP-induced non-neuronal cell permeabilization in the rat inner retina. J Neurosci (2004) 0.89
Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation. Neurochem Int (1996) 0.89
Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors. Neurosci Lett (1997) 0.89
Molecular mechanisms of microglial activation. B. Voltage- and purinoceptor-operated channels in microglia. Neurochem Int (1996) 0.89
Calcitonin gene-related peptide and ATP induce immediate early gene expression in cultured rat microglial cells. Glia (1995) 0.89
Expression of P2X4 receptor by lesional activated microglia during formalin-induced inflammatory pain. J Neuroimmunol (2005) 0.89
ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors. Neuroreport (2002) 0.88
Coexistence of purino- and pyrimidinoceptors on activated rat microglial cells. Br J Pharmacol (1997) 0.88
Adenosine triphosphate inhibits cytokine release from lipopolysaccharide-activated microglia via P2y receptors. Brain Res (2003) 0.88
Purinergic mediated changes in Ca2+ mobilization and functional responses in microglia: effects of low levels of ATP. J Neurosci Res (2005) 0.88
Upregulation of P2X(7) receptor currents in Müller glial cells during proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci (2001) 0.88
Release of adenosine and ATP in the brain of the freshwater turtle (Trachemys scripta) during long-term anoxia. Brain Res (1997) 0.88
Homo- and heteroexchange of adenine nucleotides and nucleosides in rat hippocampal slices by the nucleoside transport system. Br J Pharmacol (2003) 0.85
Mechanisms of secretion of ATP from cortical astrocytes triggered by uridine triphosphate. Neuroreport (2003) 0.85
Ecto-5'-nucleotidase is associated with cholinergic nerve terminals in the hippocampus but not in the cerebral cortex of the rat. J Neurochem (1992) 0.85
ATP acts as fast neurotransmitter in rat habenula: neurochemical and enzymecytochemical evidence. Neuroscience (1995) 0.84
Expression of inducible nitric oxide synthase mRNA and production of nitric oxide are induced by adenosine triphosphate in cultured rat microglia. Neurosci Lett (2000) 0.84
Light and electron microscopical immunocytochemistry of 5'-nucleotidase in rat cerebellum. Histochemistry (1987) 0.83
Adenosine A3 receptor-mediated regulation of p38 and extracellular-regulated kinase ERK1/2 via phosphatidylinositol-3'-kinase. Biochem Pharmacol (2004) 0.83
Monospecific antiserum against 5'-nucleotidase from Torpedo electric organ: immunocytochemical distribution of the enzyme and its association with Schwann cell membranes. Neuroscience (1988) 0.83
Regulation of K+ channel mRNA expression by stimulation of adenosine A2a-receptors in cultured rat microglia. Glia (1999) 0.83
Characterization of brain ecto-apyrase: evidence for only one ecto-apyrase (CD39) gene. Brain Res Mol Brain Res (1997) 0.82
Programmed cell death in rat microglia is controlled by extracellular adenosine. Neurosci Lett (1996) 0.81
Changes in levels of purine and pyrimidine nucleotides during acute hypoxia and recovery in neonatal rat brain. J Neurochem (1986) 0.80
P2X7 receptors in the nervous system. Prog Neurobiol (2006) 1.79
Purinergic signalling: from normal behaviour to pathological brain function. Prog Neurobiol (2011) 1.76
P2X3 receptor involvement in pain states. Mol Neurobiol (2007) 1.40
Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin. Eur J Pharmacol (2003) 1.32
Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci (2005) 1.25
Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol Ther (2005) 1.22
Modulation of hippocampal glutamatergic transmission by ATP is dependent on adenosine a(1) receptors. J Pharmacol Exp Ther (2002) 1.22
P2X7 receptor expression after ischemia in the cerebral cortex of rats. J Neuropathol Exp Neurol (2004) 1.21
P2 receptors and neuronal injury. Pflugers Arch (2006) 1.18
Inhibition of N-type voltage-activated calcium channels in rat dorsal root ganglion neurons by P2Y receptors is a possible mechanism of ADP-induced analgesia. J Neurosci (2004) 1.13
P2Y receptors and pain transmission. Purinergic Signal (2004) 1.12
Evidence for the existence of P2Y1,2,4 receptor subtypes in HEK-293 cells: reactivation of P2Y1 receptors after repetitive agonist application. Naunyn Schmiedebergs Arch Pharmacol (2005) 1.07
Pathophysiology of astroglial purinergic signalling. Purinergic Signal (2012) 1.03
The suramin analog 4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis (carbonylimino)))tetra-kis-benzenesulfonic acid (NF110) potently blocks P2X3 receptors: subtype selectivity is determined by location of sulfonic acid groups. Mol Pharmacol (2006) 0.98
Characterization of rat transient receptor potential vanilloid 1 receptors lacking the N-glycosylation site N604. Neuroreport (2005) 0.97
Amino acid residues constituting the agonist binding site of the human P2X3 receptor. J Biol Chem (2010) 0.96
Purinergic modulation of neuronal activity in the mesolimbic dopaminergic system in vivo. Synapse (2003) 0.95
Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type. Br J Pharmacol (2003) 0.95
P2 receptor signaling in neurons and glial cells of the central nervous system. Adv Pharmacol (2011) 0.95
P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses. Drug News Perspect (2005) 0.94
Characterization of P2X3, P2Y1 and P2Y4 receptors in cultured HEK293-hP2X3 cells and their inhibition by ethanol and trichloroethanol. J Neurochem (2003) 0.93
Enhanced food intake after stimulation of hypothalamic P2Y1 receptors in rats: modulation of feeding behaviour by extracellular nucleotides. Eur J Neurosci (2006) 0.92
P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone. Neuropharmacology (2013) 0.92
Supersensitivity of P2X receptors in cerebrocortical cell cultures after in vitro ischemia. J Neurochem (2005) 0.92
Regulation of human recombinant P2X3 receptors by ecto-protein kinase C. J Neurosci (2005) 0.92
Changes in purinergic signaling after cerebral injury -- involvement of glutamatergic mechanisms? Int J Dev Neurosci (2006) 0.92
Rodent cortical astroglia express in situ functional P2X7 receptors sensing pathologically high ATP concentrations. Cereb Cortex (2010) 0.92
Metabotropic P2Y1 receptors inhibit P2X3 receptor-channels in rat dorsal root ganglion neurons. Eur J Pharmacol (2005) 0.91
Clemastine potentiates the human P2X7 receptor by sensitizing it to lower ATP concentrations. J Biol Chem (2011) 0.90
P2Y(1) receptor activation inhibits NMDA receptor-channels in layer V pyramidal neurons of the rat prefrontal and parietal cortex. Neurochem Int (2003) 0.90
Dopaminergic neurons develop axonal projections to their target areas in organotypic co-cultures of the ventral mesencephalon and the striatum/prefrontal cortex. Neurochem Int (2003) 0.90
Dual effect of acid pH on purinergic P2X3 receptors depends on the histidine 206 residue. J Biol Chem (2007) 0.89
Modulation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex by P2Y receptor activation. Cereb Cortex (2006) 0.88
P2X(7) receptor-mRNA and -protein in the mouse retina; changes during retinal degeneration in BALBCrds mice. Neurochem Int (2005) 0.87
Direct inhibitory effect of fluoxetine on N-methyl-D-aspartate receptors in the central nervous system. Biol Psychiatry (2007) 0.87
Molecular determinants of potent P2X2 antagonism identified by functional analysis, mutagenesis, and homology docking. Mol Pharmacol (2010) 0.86
Interaction of P2 purinergic receptors with cellular macromolecules. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.86
Conserved lysin and arginin residues in the extracellular loop of P2X(3) receptors are involved in agonist binding. Eur J Pharmacol (2007) 0.86
Neuronal and glial cell lines as model systems for studying P2Y receptor pharmacology. Neurochem Int (2005) 0.85
Neurochemical Changes in the Mouse Hippocampus Underlying the Antidepressant Effect of Genetic Deletion of P2X7 Receptors. PLoS One (2013) 0.85
Stimulation of P2Y1 receptors causes anxiolytic-like effects in the rat elevated plus-maze: implications for the involvement of P2Y1 receptor-mediated nitric oxide production. Neuropsychopharmacology (2002) 0.85
Expression of purinergic receptors in the hypothalamus of the rat is modified by reduced food availability. Brain Res (2006) 0.84
Bridging the gap between structural bioinformatics and receptor research: the membrane-embedded, ligand-gated, P2X glycoprotein receptor. Curr Top Med Chem (2004) 0.84
Spatial and temporal aspects of Ca2+ signaling mediated by P2Y receptors in cultured rat hippocampal astrocytes. Life Sci (2002) 0.84
Adenosine A2A receptor-induced inhibition of NMDA and GABAA receptor-mediated synaptic currents in a subpopulation of rat striatal neurons. Neuropharmacology (2004) 0.84
The arginine-rich hexapeptide R4W2 is a stereoselective antagonist at the vanilloid receptor 1: a Ca2+ imaging study in adult rat dorsal root ganglion neurons. J Pharmacol Exp Ther (2002) 0.84
Cross-inhibition between native and recombinant TRPV1 and P2X(3) receptors. Pain (2009) 0.84
D1 but not D2 dopamine receptors or adrenoceptors mediate dopamine-induced potentiation of N-methyl-d-aspartate currents in the rat prefrontal cortex. Neurosci Lett (2004) 0.84
Increase of intracellular Ca2+ by adenine and uracil nucleotides in human midbrain-derived neuronal progenitor cells. Cell Calcium (2009) 0.84
Regulation of intracellular Ca2+ by P2Y1 receptors may depend on the developmental stage of cultured rat striatal neurons. J Cell Physiol (2006) 0.84
Decrease of current responses at human recombinant P2X3 receptors after substitution by Asp of Ser/Thr residues in protein kinase C phosphorylation sites of their ecto-domains. Neurosci Lett (2005) 0.83
Adenosine A2A receptors inhibit the N-methyl-D-aspartate component of excitatory synaptic currents in rat striatal neurons. Eur J Pharmacol (2002) 0.82
Interaction between P2Y and NMDA receptors in layer V pyramidal neurons of the rat prefrontal cortex. Neuropharmacology (2002) 0.82
P2X2 and P2Y1 immunofluorescence in rat neostriatal medium-spiny projection neurones and cholinergic interneurones is not linked to respective purinergic receptor function. Br J Pharmacol (2004) 0.82
VIP enhances both pre- and postsynaptic GABAergic transmission to hippocampal interneurones leading to increased excitatory synaptic transmission to CA1 pyramidal cells. Br J Pharmacol (2004) 0.82
ATP binding site mutagenesis reveals different subunit stoichiometry of functional P2X2/3 and P2X2/6 receptors. J Biol Chem (2012) 0.82
Endogenous purinergic signaling is required for osmotic volume regulation of retinal glial cells. J Neurochem (2009) 0.82
Functional regeneration of the ex-vivo reconstructed mesocorticolimbic dopaminergic system. Cereb Cortex (2012) 0.82
The P2 receptor antagonist PPADS supports recovery from experimental stroke in vivo. PLoS One (2011) 0.81
Enhanced P2Y1 receptor expression in the brain after sensitisation with d-amphetamine. Psychopharmacology (Berl) (2003) 0.81
P2Y receptor-mediated inhibition of voltage-dependent Ca2+ channels in rat dorsal root ganglion neurons. Synapse (2003) 0.81
Increase of intracellular Ca2+ by P2Y but not P2X receptors in cultured cortical multipolar neurons of the rat. J Comp Neurol (2009) 0.79
Effects of nucleotide analogs at the P2X3 receptor and its mutants identify the agonist binding pouch. Mol Pharmacol (2012) 0.79
P2Y1 receptors inhibit long-term depression in the prefrontal cortex. Neuropharmacology (2010) 0.79
Oxygen/glucose deprivation increases the integration of recombinant P2X7 receptors into the plasma membrane of HEK293 cells. Toxicology (2007) 0.79
Purinergic modulation of extracellular glutamate levels in the nucleus accumbens in vivo. Int J Dev Neurosci (2004) 0.79
Potentiation of the glutamatergic synaptic input to rat locus coeruleus neurons by P2X7 receptors. Purinergic Signal (2010) 0.78
Purine receptor-mediated endocannabinoid production and retrograde synaptic signalling in the cerebellar cortex. Br J Pharmacol (2011) 0.78
P2Y1 receptors inhibit both strength and plasticity of glutamatergic synaptic neurotransmission in the rat prefrontal cortex. Synapse (2005) 0.78
Effects of acute ethanol on the Ca2+ response to AMPA in cultured rat cortical GABAergic nonpyramidal neurons. Alcohol Alcohol (2003) 0.78
Regulation of the pH sensitivity of human P2X receptors by N-linked glycosylation. J Neurochem (2008) 0.78
Purinergic modulation of the excitatory synaptic input onto rat striatal neurons. Neuropharmacology (2011) 0.78
AMPA-induced Ca(2+) influx in cultured rat cortical nonpyramidal neurones: pharmacological characterization using fura-2 microfluorimetry. Eur J Pharmacol (2002) 0.78
Subsensitivity of P2X but not vanilloid 1 receptors in dorsal root ganglia of rats caused by cyclophosphamide cystitis. Eur J Pharmacol (2003) 0.77
P2 receptors are involved in the mediation of motivation-related behavior. Purinergic Signal (2004) 0.77
Affinity of corpora amylacea for oligonucleotides: sequence dependency and proteinaceous binding motif. Neuropathology (2006) 0.77
Blockade of glutamate transporters leads to potentiation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex via group II metabotropic glutamate receptor activation. Neuropharmacology (2008) 0.76
Up-regulation of P2X7 receptor-immunoreactivity by in vitro ischemia on the plasma membrane of cultured rat cortical neurons. Neurosci Lett (2008) 0.76
Functional P2X7 receptors at cultured hippocampal astrocytes but not neurons. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.76
The h-P2X3 glycoprotein receptor as an example of integrating bioinformatics and structural research. Expert Opin Drug Discov (2006) 0.76
Pathological potential of astroglial purinergic receptors. Adv Neurobiol (2014) 0.76
First joint Italian-German purine club meeting "Progress in Purinergic Receptor Pharmacology and Function". Purinergic Signal (2005) 0.75
Agonist antagonist interactions at the rapidly desensitizing P2X3 receptor. PLoS One (2013) 0.75
The German Research Unit "Neuronal and glial P2 receptors; molecular basis and functional significance". Purinergic Signal (2010) 0.75
Quantitative structure-activity relationship analysis of the cation permeability of the P2X2 channel. Med Chem (2005) 0.75
Modulation by D1 and D2 dopamine receptors of ATP-induced release of intracellular Ca2+ in cultured rat striatal neurons. Neurochem Int (2007) 0.75
Anoxic depolarization of hippocampal astrocytes: possible modulation by P2X7 receptors. Neurochem Int (2012) 0.75
The monomers of the P2X1 receptor model and KcsA protein share a similar structural fold. Protein Pept Lett (2006) 0.75
5,7-Dihydroxytryptamine--a selective marker of dopaminergic or serotonergic neurons? Naunyn Schmiedebergs Arch Pharmacol (2002) 0.75